Literature DB >> 23197268

Postoperative care in cataract surgery.

Bradley L Shoss1, Linda M Tsai.   

Abstract

PURPOSE OF REVIEW: The purpose of this study is to provide a summary of current trends and recent developments in postoperative care after cataract surgery. RECENT
FINDINGS: There is new evidence challenging the routine use of a protective eye shield after uncomplicated cataract surgery. Nonsteroidal anti-inflammatory drugs (NSAIDs) are effective in decreasing the risk of cystoid macular edema (CME) in high-risk eyes, but must be used with caution in patients with prior corneal disease. Pre-existing ocular comorbidities can have significant effects on postoperative outcomes. Management of postoperative visual expectations can be challenging in patients receiving newer advanced technology intraocular lenses (IOLs).
SUMMARY: Key practices such as restrictions on activities, prophylactic regimens against infection and inflammation, appropriate follow-up with adjustments for individual risk factors and management of complications, and continuing care until visual rehabilitation is complete are advised to optimize visual outcome for patients after cataract surgery.

Entities:  

Mesh:

Year:  2013        PMID: 23197268     DOI: 10.1097/ICU.0b013e32835b0716

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  7 in total

1.  Injectable drug depot engineered to release multiple ophthalmic therapeutic agents with precise time profiles for postoperative treatment following ocular surgery.

Authors:  Maziar Mohammadi; Kisha Patel; Seyedeh P Alaie; Ron B Shmueli; Cagri G Besirli; Ronald G Larson; Jordan J Green
Journal:  Acta Biomater       Date:  2018-04-21       Impact factor: 8.947

2.  Comparative study of the efficacy and safety of bromfenac, nepafenac and diclofenac sodium for the prevention of cystoid macular edema after phacoemulsification.

Authors:  Ana María Chinchurreta Capote; Mercedes Lorenzo Soto; Francisco Rivas Ruiz; Enrique Caso Peláez; Alicia García Vazquez; Antonio Ramos Suárez
Journal:  Int J Ophthalmol       Date:  2018-07-18       Impact factor: 1.779

3.  Rosmarinic Acid Restores Complete Transparency of Sonicated Human Cataract Ex Vivo and Delays Cataract Formation In Vivo.

Authors:  Marina Chemerovski-Glikman; Michael Mimouni; Yarden Dagan; Esraa Haj; Igor Vainer; Raviv Allon; Eytan Z Blumenthal; Lihi Adler-Abramovich; Daniel Segal; Ehud Gazit; Shiri Zayit-Soudry
Journal:  Sci Rep       Date:  2018-06-19       Impact factor: 4.379

4.  The influence of congenital and developmental cataract surgery on the ocular surface in a six-month follow-up prospective clinical study.

Authors:  Xiaolei Lin; Hongzhe Li; Xiyue Zhou; Xin Liu; Fan Fan; Tianke Yang; Yi Luo
Journal:  BMC Ophthalmol       Date:  2022-05-13       Impact factor: 2.209

Review 5.  Clinical outcomes after injection of a compounded pharmaceutical for prophylaxis after cataract surgery: a large-scale review.

Authors:  Sydney L Tyson; Robert Bailey; Janika S Roman; Tingting Zhan; Lisa A Hark; Julia A Haller
Journal:  Curr Opin Ophthalmol       Date:  2017-01       Impact factor: 3.761

6.  Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study.

Authors:  M E Wilson; H O'Halloran; D VanderVeen; J Roarty; D A Plager; K Markwardt; K Gedif; S R Lambert
Journal:  Eye (Lond)       Date:  2016-07-01       Impact factor: 3.775

7.  Safety and efficacy of twice daily administration of KPI-121 1% for ocular inflammation and pain following cataract surgery.

Authors:  Terry Kim; Kenneth Sall; Edward J Holland; R Kim Brazzell; Susan Coultas; Preeya K Gupta
Journal:  Clin Ophthalmol       Date:  2018-12-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.